Shira Perlmutter will discuss the Office’s priorities and major initiatives, including how the Office is implementing changes in copyright legislation and regulation, and the modernization of copyright practice. Read more
A major piece of copyright legislation, the Copyright Alternative in Small-Claims Enforcement Act (CASE Act), was tucked into the omnibus spending and COVID-19 relief bill passed by Congress on December 21, 2020. Read more
The epidemic of stress and burnout is affecting every sector of our society, but even more so the legal profession. A study by the American Bar Association found that over 25% of lawyers suffer from depression, 21% have a drinking problem, and 19% experience anxiety. Burnout and mental distress not only take a toll on the wellbeing of lawyers, but also make their clients, people, and businesses vulnerable, impairing decision-making, problem-solving, and risk management. Read more
As of this writing, the United States Food and Drug Administration (“FDA”) has approved GW Pharma’s CBD drug Epidiolex for treating profound refractory pediatric epilepsy syndromes (Dravet syndrome and Lennox Gastaut syndrome) as well as for treating seizures associated with tuberous sclerosis complex (TSC) in patients one year of age or older. Read more
On September 21, 2020 the Copyright Office announced that Librarian of Congress Carla Hayden had appointed Shira Perlmutter as Register of Copyrights and director of the U.S. Copyright Office. Perlmutter will step into the role in late October and will assume leadership of the organization during its 150th anniversary year. Read more